RT Journal Article
SR Electronic
T1 Early Experience With Tenecteplase at a Comprehensive Stroke Center
JF Neurology: Clinical Practice
FD Lippincott Williams & Wilkins
SP e885
OP e889
DO 10.1212/CPJ.0000000000001096
VO 11
IS 6
A1 Spozhmy Panezai
A1 Ilya Dubinsky
A1 Sindhu Sahito
A1 Nancy Gadallah
A1 Laura Suhan
A1 Siddhart Mehta
A1 Jawad Kirmani
YR 2021
UL http://cp.neurology.org/content/11/6/e885.abstract
AB Purpose of Review Tenecteplase has been studied and recommended as an alternative thrombolytic agent in patients with acute stroke. A brief review of clinical trials and guidelines pertinent to our clinical decision algorithm is described. This is followed by operational steps that were made to create and implement a clinical pathway based on available evidence in which tenecteplase is used in select patients with stroke at our comprehensive stroke center.Recent Findings A number of patients have been treated at our center with IV tenecteplase. A case is presented to illustrate the successful implementation of this new process.Summary Development of our protocol is discussed in detail to enable other centers to create their own clinical pathways for thrombolytic treatment of acute ischemic stroke using tenecteplase.